Suppr超能文献

沉默调节蛋白1(SIRT1)与p53:对癌症、衰老及其他方面的影响

SIRT1 and p53, effect on cancer, senescence and beyond.

作者信息

Yi Jingjie, Luo Jianyuan

机构信息

Department of Cancer Biology and the Cancer Center, University of Massachusetts Medical School, Worcester, MA, 01605, USA.

出版信息

Biochim Biophys Acta. 2010 Aug;1804(8):1684-9. doi: 10.1016/j.bbapap.2010.05.002. Epub 2010 May 13.

Abstract

NAD(+)-dependent Class III histone deacetylase SIRT1 is a multiple function protein critically involved in stress responses, cellular metabolism and aging through deacetylating a variety of substrates including p53, forkhead-box transcription factors, PGC-1alpha, NF-kappaB, Ku70 and histones. The first discovered non-histone target of SIRT1, p53, is suggested to play a central role in SIRT1-mediated functions in tumorigenesis and senescence. SIRT1 was originally considered to be a potential tumor promoter since it negatively regulates the tumor suppressor p53 and other tumor suppressors. There is new evidence that SIRT1 acts as a tumor suppressor based on its role in negatively regulating beta-catenin and survivin. This review provides an overview of current knowledge of SIRT1-p53 signaling and controversies regarding the functions of SIRT1 in tumorigenesis.

摘要

烟酰胺腺嘌呤二核苷酸(NAD⁺)依赖性Ⅲ类组蛋白去乙酰化酶SIRT1是一种多功能蛋白,通过使包括p53、叉头框转录因子、PGC-1α、核因子κB、Ku70和组蛋白在内的多种底物去乙酰化,在应激反应、细胞代谢和衰老过程中发挥关键作用。SIRT1首个被发现的非组蛋白靶点p53,被认为在SIRT1介导的肿瘤发生和衰老功能中起核心作用。SIRT1最初被认为是一种潜在的肿瘤促进因子,因为它对肿瘤抑制因子p53和其他肿瘤抑制因子起负调控作用。基于其对β-连环蛋白和生存素的负调控作用,有新证据表明SIRT1可作为肿瘤抑制因子。本文综述了目前关于SIRT1-p53信号传导的知识以及SIRT1在肿瘤发生中功能的争议。

相似文献

1
SIRT1 and p53, effect on cancer, senescence and beyond.
Biochim Biophys Acta. 2010 Aug;1804(8):1684-9. doi: 10.1016/j.bbapap.2010.05.002. Epub 2010 May 13.
2
Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming.
Ageing Res Rev. 2018 May;43:64-80. doi: 10.1016/j.arr.2018.02.004. Epub 2018 Feb 21.
3
The role of SIRT1 in tumorigenesis.
N Am J Med Sci (Boston). 2011;4(2):104-106. doi: 10.7156/v4i2p104.
5
Sirtuin1-p53: A potential axis for cancer therapy.
Biochem Pharmacol. 2023 Jun;212:115543. doi: 10.1016/j.bcp.2023.115543. Epub 2023 Apr 8.
6
Insulin-like growth factor-1 regulates the SIRT1-p53 pathway in cellular senescence.
Aging Cell. 2014 Aug;13(4):669-78. doi: 10.1111/acel.12219. Epub 2014 Apr 30.
7
Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress.
PLoS One. 2013 Sep 11;8(9):e73875. doi: 10.1371/journal.pone.0073875. eCollection 2013.
9
Redox regulation of SIRT1 in inflammation and cellular senescence.
Free Radic Biol Med. 2013 Aug;61:95-110. doi: 10.1016/j.freeradbiomed.2013.03.015. Epub 2013 Mar 27.
10
LARP7 ameliorates cellular senescence and aging by allosterically enhancing SIRT1 deacetylase activity.
Cell Rep. 2021 Nov 23;37(8):110038. doi: 10.1016/j.celrep.2021.110038.

引用本文的文献

1
Involvement of NRF2 and AMPK signaling in aging and progeria: a digest.
Redox Biol. 2025 Jul 21;85:103782. doi: 10.1016/j.redox.2025.103782.
2
CD38-NAD(+) Axis: New Insights into Glaucoma Therapy.
Mol Neurobiol. 2025 Jul 22. doi: 10.1007/s12035-025-05243-3.
5
Therapeutic potential of microRNA-506 in cancer treatment: mechanisms and therapeutic implications.
Front Oncol. 2025 Apr 3;15:1524763. doi: 10.3389/fonc.2025.1524763. eCollection 2025.
8
Dietary Restrictions and Cancer Prevention: State of the Art.
Nutrients. 2025 Jan 29;17(3):503. doi: 10.3390/nu17030503.
9
Role of sirtuin 1 in depression‑induced coronary heart disease: Molecular pathways and therapeutic potential (Review).
Biomed Rep. 2025 Jan 14;22(3):46. doi: 10.3892/br.2025.1924. eCollection 2025 Mar.
10
Recent Advances in the Clinical Translation of Small-Cell Lung Cancer Therapeutics.
Cancers (Basel). 2025 Jan 14;17(2):255. doi: 10.3390/cancers17020255.

本文引用的文献

1
Caloric restriction, SIRT1 and longevity.
Trends Endocrinol Metab. 2009 Sep;20(7):325-31. doi: 10.1016/j.tem.2009.03.008. Epub 2009 Aug 25.
2
Sirtuin activators.
Expert Opin Ther Pat. 2009 Apr;19(4):403-14. doi: 10.1517/13543770902762893.
3
Sirtuin inhibitors.
Expert Opin Ther Pat. 2009 Mar;19(3):283-94. doi: 10.1517/13543770902755111.
4
Inhibition of SUV39H1 methyltransferase activity by DBC1.
J Biol Chem. 2009 Apr 17;284(16):10361-6. doi: 10.1074/jbc.M900956200. Epub 2009 Feb 13.
5
SIRT1, is it a tumor promoter or tumor suppressor?
Int J Biol Sci. 2009;5(2):147-52. doi: 10.7150/ijbs.5.147. Epub 2009 Jan 21.
6
How does SIRT1 affect metabolism, senescence and cancer?
Nat Rev Cancer. 2009 Feb;9(2):123-8. doi: 10.1038/nrc2562. Epub 2008 Dec 29.
7
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.
Oncogene. 2009 Feb 12;28(6):781-91. doi: 10.1038/onc.2008.436. Epub 2008 Dec 8.
8
Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis.
Mol Cell. 2008 Oct 10;32(1):11-20. doi: 10.1016/j.molcel.2008.09.011.
9
Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.
Cancer Cell. 2008 Oct 7;14(4):312-23. doi: 10.1016/j.ccr.2008.09.001.
10
miR-34a repression of SIRT1 regulates apoptosis.
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13421-6. doi: 10.1073/pnas.0801613105. Epub 2008 Aug 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验